We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
+$149M
Cap. Flow
-$135M
Cap. Flow %
-1.45%
Top 10 Hldgs %
16.19%
Holding
2,678
New
110
Increased
434
Reduced
834
Closed
256

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$20.5M
3
DOW icon
Dow Inc
DOW
+$10.9M
4
ENB icon
Enbridge
ENB
+$8.91M
5
CTVA icon
Corteva
CTVA
+$5.55M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.4M
2
MUB icon
iShares National Muni Bond ETF
MUB
+$12.8M
3
DD icon
DuPont de Nemours
DD
+$10.6M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$8.73M
5
MSFT icon
Microsoft
MSFT
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Financials 14.84%
3 Healthcare 12.76%
4 Industrials 10.2%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCRN
2176
DELISTED
Cross Country Healthcare
CCRN
$155K ﹤0.01%
16,495
– –
AMBR
2177
DELISTED
Amber Road Inc
AMBR
$154K ﹤0.01%
+11,825
New +$133K
SMMF
2178
DELISTED
Summit Financial Group, Inc.
SMMF
$153K ﹤0.01%
5,705
– –
TLRA
2179
DELISTED
Telaria, Inc.
TLRA
$153K ﹤0.01%
20,315
– –
SMHI icon
2180
SEACOR Marine Holdings
SMHI
$262M
$153K ﹤0.01%
+10,207
New +$141K
PAR icon
2181
PAR Technology
PAR
$770M
$152K ﹤0.01%
5,391
– –
ALBO
2182
DELISTED
Albireo Pharma Inc
ALBO
$152K ﹤0.01%
4,713
– –
MTUS icon
2183
Metallus
MTUS
$892M
$151K ﹤0.01%
18,629
– –
RFL icon
2184
Rafael Holdings
RFL
$102M
$151K ﹤0.01%
+5,337
New +$91.9K
DNTH icon
2185
Dianthus Therapeutics
DNTH
$6.13B
$151K ﹤0.01%
+641
New +$158K
ODT
2186
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$151K ﹤0.01%
+4,120
New +$98.7K
TRC icon
2187
Tejon Ranch
TRC
$443M
$151K ﹤0.01%
9,079
– –
ZYNE
2188
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$150K ﹤0.01%
+11,100
New +$128K
LXRX icon
2189
Lexicon Pharmaceuticals
LXRX
$1.04B
$150K ﹤0.01%
23,843
– –
BFYT
2190
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$150K ﹤0.01%
5,782
– –
GRTS
2191
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$150K ﹤0.01%
+13,449
New +$154K
CLAR icon
2192
Clarus
CLAR
$145M
$150K ﹤0.01%
10,418
– –
RYAM icon
2193
Rayonier Advanced Materials
RYAM
$570M
$149K ﹤0.01%
22,944
– –
MITK icon
2194
Mitek Systems
MITK
$853M
$149K ﹤0.01%
14,980
– –
CFMS
2195
DELISTED
Conformis, Inc. Common Stock
CFMS
$149K ﹤0.01%
+1,364
New +$112K
DSPG
2196
DELISTED
DSP Group Inc
DSPG
$148K ﹤0.01%
+10,337
New +$149K
CTO
2197
CTO Realty Growth
CTO
$823M
$148K ﹤0.01%
+9,155
New +$150K
ATEN icon
2198
A10 Networks
ATEN
$1.96B
$148K ﹤0.01%
21,727
– –
MCBC
2199
DELISTED
Macatawa Bank Corp
MCBC
$148K ﹤0.01%
14,416
– –
PETS icon
2200
PetMed Express
PETS
$43.4M
$148K ﹤0.01%
9,436
– –
86 87
88
89 90

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, MetLife Investment Management held 2,678 positions worth $9.35B, up 1.6% from $9.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q2 2019 filing shows 110 new, 434 increased, 834 reduced and 256 closed positions. Its largest new stake was Dow Inc: 206,405 shares worth $10.2M. The largest sale was Apple, an estimated $13.4M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2019 buy was Dow Inc: 206,405 shares worth $10.2M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $62.7M increase.
  • MetLife Investment Management's biggest Q2 2019 reduction was Apple, cutting an estimated $13.4M.
  • MetLife Investment Management fully exited iShares National Muni Bond ETF in Q2 2019, selling an estimated $12.8M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.35B portfolio in Q2 2019.
  • MetLife Investment Management opened 110 new positions and closed 256 in Q2 2019.
  • MetLife Investment Management's portfolio value rose 1.6% quarter-over-quarter to $9.35B.

Based on MetLife Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.